Markets.com Logo

INNA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    20.6414$
  • Previous Close
    20.6414$
  • 52 Week Change
    8.04$
  • Day Range
    0.00$
  • 52 Week High/Low
    12.9626$ - 21$
  • Dividend Per Share
    0.051
  • Market cap
    62 993 M$
  • EPS
    0.3145
  • Beta
    1.28
  • Volume
    --

About

INNA.F represents the stock of Innate Pharma S.A., a French biotechnology company focused on discovering, developing and commercializing first-in-class immunotherapies for cancer. The company's shares are listed on the Euronext Paris exchange under this ticker symbol. Investors can trade INNA.F shares during market hours through brokerage accounts that allow access to the Euronext Paris market.
Why SpaceX's $2 Trillion Listing Is a Watershed for Middle East CFD Traders

Why SpaceX's $2 Trillion Listing Is a Watershed for Middle East CFD Traders

Julian Parker|--
SpaceX IPO Aftermath: High-Conviction CFD Strategies for Middle East Investors

SpaceX IPO Aftermath: High-Conviction CFD Strategies for Middle East Investors

Julian Parker|--
Gulf Capital Fuels the SpaceX IPO: What Sovereign Money Signals for Middle East CFD Traders

Gulf Capital Fuels the SpaceX IPO: What Sovereign Money Signals for Middle East CFD Traders

Julian Parker|--
From Pretoria to Trillionaire: What the SpaceX (SPCX) IPO Means for South African CFD Traders

From Pretoria to Trillionaire: What the SpaceX (SPCX) IPO Means for South African CFD Traders

Julian Parker|--
Trading SPCX Volatility: A Risk-Management Playbook for South African CFD Traders

Trading SPCX Volatility: A Risk-Management Playbook for South African CFD Traders

Julian Parker|--
SpaceX, Starlink and the Rand: How South African Traders Can Play the $2 Trillion Connectivity Story

SpaceX, Starlink and the Rand: How South African Traders Can Play the $2 Trillion Connectivity Story

Julian Parker|--
SpaceX IPO Underwriting Fees: What the 0.7% Spread Reveals About Wall Street

SpaceX IPO Underwriting Fees: What the 0.7% Spread Reveals About Wall Street

Julian Parker|--

Factors

Industry Trends: Biotechnology sector performance influences investor sentiment.

Company Performance: Revenue, earnings, and clinical trial results impact stock value.

Regulatory Approvals: FDA decisions on Innate Pharma's products affect price.

Market Sentiment: General investor confidence and risk appetite play a role.

Competition: Actions of rival companies influence Innate Pharma's market position.

People Also Watch

Latest news

Gold Price Today, June 15: Spot Gold Surges 2% to $4,304 on US-Iran Peace Deal

Gold Price Today, June 15: Spot Gold Surges 2% to $4,304 on US-Iran Peace Deal

Julian Parker|--
Oil Prices Fall as U.S.-Iran Ceasefire Eases Hormuz Supply Risk

Oil Prices Fall as U.S.-Iran Ceasefire Eases Hormuz Supply Risk

Julian Parker|--

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Sophia Claire|--

Latest Education Articles

SpaceX vs Saudi Aramco: The Largest IPO in History — What GCC Traders Need to Know

SpaceX vs Saudi Aramco: The Largest IPO in History — What GCC Traders Need to Know

Julian Parker|--
Trading the SpaceX (SPCX) Debut from the UAE: A CFD Trader's Guide

Trading the SpaceX (SPCX) Debut from the UAE: A CFD Trader's Guide

Julian Parker|--
Pre-IPO Investing: How It Works, Risks and Trading Alternatives

Pre-IPO Investing: How It Works, Risks and Trading Alternatives

Julian Parker|--
Recommended Topics